Trademark: 86463444
Word
BRINTELLIX
Status
Dead
Status Code
710
Status Date
Friday, July 8, 2022
Serial Number
86463444
Registration Number
4873004
Registration Date
Tuesday, December 22, 2015
Mark Type
3000
Filing Date
Monday, November 24, 2014
Published for Opposition
Tuesday, October 6, 2015
Cancellation Date
Friday, July 8, 2022

Trademark Owner History
H. Lundbeck A-S - Original Registrant

Classifications
41 Education services, namely, providing continuing medical education courses; providing of training, namely, medical training and teaching; arranging and conducting educational seminars, conferences, symposiums, workshops, training and courses in the field of medicine; educational classes, courses, seminars and workshops and training services in the field of research and development for the treatment and prevention of brain and central nervous system diseases and disorders, science, clinical tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention; educational services, namely, seminars, conferences, symposiums, workshops, training and courses and training services in the field of medical research and development, science, clinical tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention of disease provided electronically, on-line, via the Internet and global communications networks; education services, namely, arranging and conducting of expert forums, in the form of seminars, conferences, symposia, workshops and courses in the field of medicine; educational services, namely, providing medical training online; providing non-downloadable, on-line publications, namely, books, reports, brochures, booklets, leaflets, including patient information leaflets, magazines, journals, teaching and educational material in the nature of articles, journals in the field of medical research and development, science, clinical tests and trials, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, treatment and prevention of disease
5 Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease and disorder, stroke, depression, mood disorders, psychosis, anxiety, epilepsy, sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, ADHD, oncology, pain, alcoholism and dependency; medical diagnostic preparations for medical purposes, reagents for medical use, diagnostic agents preparations and substances for medical purposes
44 Medical services in the field of psychiatry and psychology, namely, medical advice related to medical and pharmaceutical preparations and substances; medical clinical services in the field of the treatment and prevention of brain and central nervous system diseases and disorders; medical treatment services in the field of the treatment and prevention of brain and central nervous system diseases and disorders; therapeutic treatment services in the field of the treatment and prevention of brain and central nervous system diseases and disorders; therapeutic clinical services in the field of the treatment and prevention of brain and central nervous system diseases and disorders; healthcare and medical services related to central nervous system and brain disorders, diseases and pharmaceuticals; providing information relating to diagnostic and therapeutic properties of pharmaceuticals in the field of disorders, diseases, treatment and prevention; providing medical information services; providing on-line medical data and analyses designed to provide patients and clients customized information, including medical dose, diagnosis, therapeutic issues and medical management; providing an online database in the field of medical diagnosis and treatment of brain and central nervous system diseases and disorders
42 Scientific and technological services, namely, scientific research in the field of medicine; industrial analysis in the nature of research services in the field of pharmaceuticals; providing online non-downloadable software in the field of research and development for use in database management in the field of the treatment and prevention of brain and central nervous system diseases and disorder and an online searchable database in the field of scientific research and development of clinical tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention all for the purpose of scientific research; providing a secured-access website that gives registered medical experts the ability to upload, view, download, and share documents and images for the purposes of research and development in the field of clinical tests and trials, science, patient diagnostics, medicine, pharmaceuticals, disorders, diseases, treatment and prevention of disease; pharmaceutical research and development; scientific and technological services, namely, research in the field of medical disorders, diseases and prevention of disease; scientific and technological services, namely, scientific research in the field of the treatment and prevention of brain and central nervous system related disorders, diseases and pharmaceuticals; medical research, conducting clinical medical trials and testing in the field of pharmaceuticals for others; medical services, namely, medical research; medical diagnostic research and tests, namely, clinical trials for others; providing medical research information in the field of pharmaceutical research and development, clinical tests and trials
The mark consists of the stylized characters "BRINTELLIX" in blue-green and the dot over the first letter "I" represented by concentric orange circles where an upper portion of each circle is faded out. The white background represents transparent regions and is not claimed as part of the mark.
The color(s) blue-green and orange is/are claimed as a feature of the mark.
The wording "BRINTELLIX" has no meaning in a foreign language.

Trademark Events
Jul 8, 2022
Cancelled Sec. 8 (6-Yr)
Dec 22, 2020
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Dec 22, 2015
Registered-Principal Register
Oct 6, 2015
Official Gazette Publication Confirmation E-Mailed
Oct 6, 2015
Published For Opposition
Sep 16, 2015
Notification Of Notice Of Publication E-Mailed
Sep 3, 2015
Law Office Publication Review Completed
Sep 3, 2015
Approved For Pub - Principal Register
Sep 2, 2015
Teas/Email Correspondence Entered
Sep 2, 2015
Correspondence Received In Law Office
Sep 2, 2015
Teas Response To Office Action Received
Sep 1, 2015
Notification Of Non-Final Action E-Mailed
Sep 1, 2015
Non-Final Action E-Mailed
Sep 1, 2015
Non-Final Action Written
Aug 11, 2015
Teas/Email Correspondence Entered
Aug 11, 2015
Correspondence Received In Law Office
Aug 4, 2015
Assigned To Lie
Jul 22, 2015
Teas Response To Office Action Received
Feb 10, 2015
Notification Of Non-Final Action E-Mailed
Feb 10, 2015
Non-Final Action E-Mailed
Feb 10, 2015
Non-Final Action Written
Feb 10, 2015
Assigned To Examiner
Dec 3, 2014
Notice Of Design Search Code E-Mailed
Dec 2, 2014
New Application Office Supplied Data Entered In Tram
Nov 27, 2014
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24